logo

For the Inventor, By the Inventor

Canterbury, United Kingdom

John Edward Kemp

This inventor holds 9 USPTO granted patents. Top assignee: Pfizer Corporation. Active years: 1976-1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Edward Kemp. Retrieved from https://idiyas.com/inventor/john-edward-kemp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 5

Forward Citations = 61(Granted Patents)


Location History:

  • Canterbury, EN (1976 - 1977)
  • Canterbury, GB (1982 - 1995)

Company Filing History:

goldMedal9 out of 4,488 
 
Pfizer Corporation
 patents

Years Active: 1976-1995

Loading Chart...
9 patents (USPTO):Explore Patents
1. 5397800 - Certain 1-azabicyclo[2.2.1]heptanes useful as muscarinic receptor (1995-03-14),
2. 4797401 - 4-Substituted-1-(4-alkylsulphonamidophenyl)piperazines as antiarrhythmic (1989-01-10),
3. 4356122 - 6-Perhaloalkylsulfonyloxy-penicillanic acids and derivatives thereof (1982-10-26),
4. 4044136 - Aminoquinazoline therapeutic agents (1977-08-23),
5. 3970757 - Tetrahydro-carbazole derivatives as gastric anti-secretory agents (1976-07-20),
6. 3961072 - Phenoxypropanolamine therapeutic agents (1976-06-01),
7. 3960861 - 2 (OR 4) Amino 4 (or 2) N-hetero quinazolines (1976-06-01),
8. 3951983 - Phenoxypropanolpiperazines (1976-04-20),
9. 3931222 - Tetrahydro-carbazole derivates (1976-01-06),

Title: John Edward Kemp: Innovator in Pharmaceutical Chemistry

Introduction

John Edward Kemp is a notable inventor based in Canterbury, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 9 patents. His work focuses on developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents are several groundbreaking inventions. These include "Certain 1-azabicyclo[2.2.1]heptanes useful as muscarinic receptor," "4-Substituted-1-(4-alkylsulphonamidophenyl)piperazines as antiarrhythmic," and "Antiarrhythmic agents of the formula: ##STR1## and their pharmaceutically acceptable salts, wherein R and R.sup.1, which are the same or different, are C.sub.1 -C.sub.4 alkyl, C.sub.3 -C.sub.7 cycloalkyl, --CH.sub.2 CH.sub.3, --CH.sub.2 Cl, --CF.sub.3 or --NH.sub.2."

Career Highlights

John Edward Kemp has built a successful career at Pfizer Corporation, where he continues to innovate and contribute to the development of new pharmaceutical agents. His expertise in medicinal chemistry has positioned him as a key player in the industry.

Collaborations

Throughout his career, Kemp has collaborated with esteemed colleagues, including Peter E Cross and John C Danilewicz. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

John Edward Kemp's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field and advance therapeutic options for various medical conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…